Literature DB >> 339670

Polypharmacy among psychiatric patients.

E Hemminki.   

Abstract

The purpose of the present study is to determine the frequency of polypharmacy among psychiatric patients in Helsinki, and to ascertain whether this practice is supported by clinical trials. The drugs prescribed in 1 day to a sample of patients (n = 694) in mental hospitals and outpatient clinics in Helsinki were studied. 69% of patients received more than on psychotropic drug in 1 day (61% received "proper" psychotropic drugs). On the average there were 2.1 different psychotropic drugs per patient, and the maximum was 6. A review of controlled clinical trials on the simultaneous use of more than one proper psychotropic drug in psychiatric diseases (excluding fixed combinations) revealed 14 trials. In only three trials was the combination better than its single components or placebo. Thus, there seems to be no evidence from clinical trials defending the frequent polypharmacy. A radical reduction in the number of psychotropic drugs prescribed for psychiatric patients is apparently desirable.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 339670     DOI: 10.1111/j.1600-0447.1977.tb06676.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  8 in total

1.  Utilisation of psychotropic drugs in patients of the long stay ward.

Authors:  F El Hefny; M K Al Haddad; V Mathur
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

2.  Drug surveillance programme in psychiatry - adverse durg reactions.

Authors:  L P Shah; K S Ayyar; B R Agarawal; P V Pradhan; V N Bagadia; K C Gupta; T Paul; H Santhanam; U K Sheth
Journal:  Indian J Psychiatry       Date:  1983-07       Impact factor: 1.759

Review 3.  Antipsychotic polypharmacy in schizophrenia: benefits and risks.

Authors:  Thomas R E Barnes; Carol Paton
Journal:  CNS Drugs       Date:  2011-05       Impact factor: 5.749

4.  Concurrent use of more than one major psychotropic drug (polypsychopharmacy) in out-patients--a prescription database study.

Authors:  J U Rosholm; J Hallas; L F Gram
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

5.  Why are psychotropic drugs prescribed to out-patients? A methodological study.

Authors:  U Bergman; M Dahlström; C Gunnarsson; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

6.  Drug treatment of psychiatric patients in general practice.

Authors:  P Tyrer
Journal:  Br Med J       Date:  1978-10-07

7.  Polypharmacy-induced cognitive dysfunction and discontinuation of psychotropic medication: a neuropsychological case report.

Authors:  Jussi Valtonen; Mira Karrasch
Journal:  Ther Adv Psychopharmacol       Date:  2020-04-28

Review 8.  Defining pediatric polypharmacy: A scoping review.

Authors:  Paul M Bakaki; Alexis Horace; Neal Dawson; Almut Winterstein; Jennifer Waldron; Jennifer Staley; Elia M Pestana Knight; Sharon B Meropol; Rujia Liu; Hannah Johnson; Negar Golchin; James A Feinstein; Shari D Bolen; Lawrence C Kleinman
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.